335 related articles for article (PubMed ID: 14572810)
1. The pathogenesis of hereditary angioedema.
Davis AE
Transfus Apher Sci; 2003 Dec; 29(3):195-203. PubMed ID: 14572810
[TBL] [Abstract][Full Text] [Related]
2. The pathophysiology of hereditary angioedema.
Davis AE
Clin Immunol; 2005 Jan; 114(1):3-9. PubMed ID: 15596403
[TBL] [Abstract][Full Text] [Related]
3. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor.
Han ED; MacFarlane RC; Mulligan AN; Scafidi J; Davis AE
J Clin Invest; 2002 Apr; 109(8):1057-63. PubMed ID: 11956243
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of hereditary angioedema.
Zuraw BL; Christiansen SC
Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
[TBL] [Abstract][Full Text] [Related]
5. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
Cugno M; Zanichelli A; Foieni F; Caccia S; Cicardi M
Trends Mol Med; 2009 Feb; 15(2):69-78. PubMed ID: 19162547
[TBL] [Abstract][Full Text] [Related]
6. Structure and regulation of the C1 inhibitor gene.
Zahedi K; Prada AE; Davis AE
Behring Inst Mitt; 1993 Dec; (93):115-9. PubMed ID: 8172557
[TBL] [Abstract][Full Text] [Related]
7. Novel therapies for hereditary angioedema.
Zuraw BL
Immunol Allergy Clin North Am; 2006 Nov; 26(4):691-708. PubMed ID: 17085285
[TBL] [Abstract][Full Text] [Related]
8. C1 inhibitor, a multi-functional serine protease inhibitor.
Davis AE; Lu F; Mejia P
Thromb Haemost; 2010 Nov; 104(5):886-93. PubMed ID: 20806108
[TBL] [Abstract][Full Text] [Related]
9. Approaches toward reversal of increased vascular permeability in C1 inhibitor deficient mice.
Han Lee ED; Pappalardo E; Scafidi J; Davis AE
Immunol Lett; 2003 Oct; 89(2-3):155-60. PubMed ID: 14556973
[TBL] [Abstract][Full Text] [Related]
10. Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema.
Gösswein T; Kocot A; Emmert G; Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Bork K; Oldenburg J; Müller CR
Cytogenet Genome Res; 2008; 121(3-4):181-8. PubMed ID: 18758157
[TBL] [Abstract][Full Text] [Related]
11. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.
Zahedi R; Wisnieski J; Davis AE
J Immunol; 1997 Jul; 159(2):983-8. PubMed ID: 9218620
[TBL] [Abstract][Full Text] [Related]
12. Normal C1 inhibitor mRNA expression level in type I hereditary angioedema patients: newly found C1 inhibitor gene mutations.
Kang HR; Yim EY; Oh SY; Chang YS; Kim YK; Cho SH; Min KU; Kim YY
Allergy; 2006 Feb; 61(2):260-4. PubMed ID: 16409206
[TBL] [Abstract][Full Text] [Related]
13. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
Busse P; Kaplan A
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
[TBL] [Abstract][Full Text] [Related]
14. The bradykinin-forming cascade and its role in hereditary angioedema.
Kaplan AP; Joseph K
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
[TBL] [Abstract][Full Text] [Related]
15. The effect of C1 inhibitor on intestinal ischemia and reperfusion injury.
Lu F; Chauhan AK; Fernandes SM; Walsh MT; Wagner DD; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G1042-9. PubMed ID: 18787060
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and laboratory diagnosis of hereditary angioedema.
Zuraw BL; Christiansen SC
Allergy Asthma Proc; 2009; 30(5):487-92. PubMed ID: 19843402
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.
Veronez CL; Christiansen SC; Smith TD; Riedl MA; Zuraw BL
Allergy Asthma Proc; 2021 Nov; 42(6):506-514. PubMed ID: 34871158
[No Abstract] [Full Text] [Related]
18. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy.
Kaplan AP
J Allergy Clin Immunol; 2010 Nov; 126(5):918-25. PubMed ID: 20889195
[TBL] [Abstract][Full Text] [Related]
19. Current update on cellular and molecular mechanisms of hereditary angioedema.
Walford HH; Zuraw BL
Ann Allergy Asthma Immunol; 2014 May; 112(5):413-8. PubMed ID: 24484972
[TBL] [Abstract][Full Text] [Related]
20. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
